Dan Aderka
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Immunology 29
- Immune Response and Inflammation 13
- Immune Cell Function and Interaction 8
- Immunotherapy and Immune Responses 8
- Oncology 28
- Colorectal Cancer Treatments and Studies 12
- Colorectal Cancer Surgical Treatments 8
- Co-authors
- David Wallach (29 shared papers)Hartmut Engelmann (16 shared papers)Cord Herbert Brakebusch (4 shared papers)J Vilček (1 shared paper)Junming Le (2 shared papers)Yasmin Maor (5 shared papers)Y Levo (18 shared papers)Helmut Holtmann (10 shared papers)
- Journals
- Cancer (5 papers)Annals of Oncology (5 papers)Acta Haematologica (3 papers)JAMA (3 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Dan Aderka
123 papers receiving 9.8k citations
Dan Aderka's Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 3.7k
- Hepatology 1.0k
- Immunology 2.2k
- Cancer Research 1.0k
- Pathology and Forensic Medicine 909
Countries citing papers authored by Dan Aderka
This map shows the geographic impact of Dan Aderka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Aderka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Aderka more than expected).
Fields of papers citing papers by Dan Aderka
This network shows the impact of papers produced by Dan Aderka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Aderka. The network helps show where Dan Aderka may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Aderka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Hit paper breakdown → | 2016 | 2659 |
| 2 | ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making Hit paper breakdown → | 2012 | 1219 |
| 3 | Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. Hit paper breakdown → | 1992 | 741 |
| 4 | 1989 | 527 | |
| 5 | 1994 | 407 | |
| 6 | 1989 | 397 | |
| 7 | Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers Hit paper breakdown → | 2014 | 359 |
| 8 | 1992 | 303 | |
| 9 | 1990 | 297 | |
| 10 | 1996 | 252 | |
| 11 | Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. | 1991 | 216 |
| 12 | Letter: Thoracic-duct cannulation for bleeding oesophageal varices. | 1976 | 172 |
| 13 | 2019 | 164 | |
| 14 | 2019 | 162 | |
| 15 | 1993 | 158 | |
| 16 | 1986 | 156 | |
| 17 | Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. | 2007 | 134 |
| 18 | Variation in serum levels of the soluble TNF receptors among healthy individuals. | 1992 | 125 |
| 19 | 1985 | 112 | |
| 20 | 2007 | 105 |
About Dan Aderka
Dan Aderka is a scholar working on Immunology, Oncology, Genetics, Hepatology and Pathology and Forensic Medicine, having authored 135 papers that have together received 10.2k indexed citations. Recurring topics across this work include Immune Response and Inflammation (13 papers), Colorectal Cancer Treatments and Studies (12 papers), Colorectal Cancer Surgical Treatments (8 papers), Chronic Lymphocytic Leukemia Research (8 papers), Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (3.7k citations), Hepatology (1.0k citations), Immunology (2.2k citations), Cancer Research (1.0k citations) and Pathology and Forensic Medicine (909 citations). Dan Aderka has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include David Wallach, Hartmut Engelmann, Cord Herbert Brakebusch, J Vilček, Junming Le, Yasmin Maor, Y Levo, Helmut Holtmann, Richard D R Camp and Menachem Rubinstein. Their work appears in journals such as Cancer, Annals of Oncology, Acta Haematologica, JAMA and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.